Exploring your options for Chronic Thrombocytopenia in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Chronic Thrombocytopenia Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Featured
Here are the most reputed hospitals in India for Chronic Thrombocytopenia Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Chronic thrombocytopenia is a long-term condition in which the platelet count — the blood cells responsible for clotting — remains persistently low, usually defined as lasting beyond twelve months. The most common cause in adults is chronic immune thrombocytopenia (ITP), an autoimmune condition in which the immune system mistakenly destroys platelets. Treatment is highly individualised: some patients with mildly low counts and no bleeding symptoms require only regular monitoring, while others need medications to suppress the immune attack or stimulate platelet production, and a smaller group may benefit from surgical removal of the spleen. Modern options including thrombopoietin receptor agonists and rituximab have expanded the range of effective long-term therapies, and the overall goal is to maintain a platelet count that prevents serious bleeding while preserving quality of life.
Ongoing monitoring with or without oral medications — steroids, TPO-receptor agonists, or IVIG — to keep platelet counts in a safe range without surgery.
Estimated cost: ~$200 – $500
Typical tests: Complete blood count (CBC) with differential, Peripheral blood smear, Liver function tests (LFT), Kidney function tests (KFT), Thyroid function tests (TSH, free T4), Hepatitis B, C, and HIV serology, ANA and antiphospholipid antibody panel, H. pylori testing (urea breath test or stool antigen). Done in India before admission.
Estimated cost in India: $500 – $2,500
Treatment duration in India: ~3 weeks (~5 hospital visit days across the full span)
A course of four weekly rituximab infusions targeting the B cells that produce platelet-destroying antibodies, used when steroids or TPO agents have not achieved lasting remission.
Estimated cost: ~$200 – $500
Typical tests: Complete blood count (CBC) with differential, Liver function tests (LFT), Kidney function tests (KFT), Hepatitis B surface antigen and hepatitis B core antibody (mandatory before rituximab), Hepatitis C antibody and HIV serology, Immunoglobulin levels (IgG, IgA, IgM), ANA and antiphospholipid antibody panel, ECG (cardiac baseline). Done in India before admission.
Estimated cost in India: $2,500 – $5,000
Treatment duration in India: ~4 weeks (~8 hospital visit days across the full span)
Keyhole surgery to remove the spleen — the organ where platelets are destroyed — offering potential long-term remission for patients who have not responded to medical treatments.
Estimated cost: ~$500 – $1,000
Typical tests: Complete blood count (CBC) with differential, Coagulation profile (PT, aPTT, INR), Liver function tests (LFT), Kidney function tests (KFT), Blood group and cross-match, ECG, Chest X-ray, Abdominal ultrasound or CT scan to assess spleen size and accessory spleens, Anaesthesia fitness evaluation. Done in India before admission.
Estimated cost in India: $4,000 – $8,000
Pre-procedure stay (outside hospital): ~3 days
Hospitalisation: ~5 days
Recovery period (outside hospital): ~14 days recommended
Total stay: approx 22 days
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.
